UroGen Pharma Ltd. (URGN) stock
URGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.87+1.77 (+6.30%)
Close on Nov 17, 2026Market cap $1.46BP/E –Yield –
UroGen Pharma EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
UroGen Pharma's EV/EBITDA was 92.1× on Jan 31, 2018.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2018 | Jan 31, 2018 | 92.1× | +27.5 |
| 2017 | Dec 29, 2017 | 64.6× | – |
See a number that looks wrong?